5-Fluoro-AMT
5-Fluoro-αMT, also known as 5-fluoro-α-methyltryptamine or by its developmental code names PAL-212 and PAL-544, is a monoaminergic drug of the tryptamine and α-alkyltryptamine families related to α-methyltryptamine. It is taken orally.
The drug is known to act as a serotonin receptor agonist, monoamine releasing agent, and potent monoamine oxidase inhibitor. It produces psychedelic- and stimulant-like effects in animals. 5-Fluoro-AMT is also known to be psychoactive in humans, though its effects have not been well-described.
5-Fluoro-AMT was first described in the scientific literature by 1963. There has been interest in 5-fluoro-AMT as a possible treatment for cocaine dependence.
Use and effects
5-Fluoro-AMT has been said to be psychoactive in humans at a dose of 25mg orally, although the qualitative nature of these effects has not been well-described. Preclinical studies suggest that 5-fluoro-αMT may be a psychedelic, stimulant, and/or entactogen in humans. However, 5-fluoro-AMT may be dangerous in humans due to its concomitant potent monoamine oxidase inhibition.William Leonard Pickard has described his experiences with 5-fluoro-AMT, which he had synthesized along with 6-fluoro-AMT, in personal interviews. According to Pickard, 5-fluoro-AMT had a duration of at minimum 9hours and varied in length significantly. The dose was 25mg and above. Pickard has said that 5-fluoro-AMT was not a "warm drug" but that he remained favorable to it. Its effects included time dilation among others. He said that it gave him the worst post-trip headaches he'd experienced from any psychedelic and they lasted up to 24hours.
Pickard has said that 5-fluoro-AMT is less potent and long-lasting than 6-fluoro-AMT. The related drug AMT was one of Pickard's favorite psychedelics, and he said that he took it more than 50times and experienced no negative side effects with it.
Interactions
Pharmacology
Pharmacodynamics
5-Fluoro-AMT has been found to act as a fairly balanced serotonin-norepinephrine-dopamine releasing agent, as a serotonin 5-HT2A receptor agonist, and as a potent and specific MAO-A inhibitor. Its values in terms of monoamine release are 14 to 19nM for serotonin, 78 to 126nM for norepinephrine, and 32 to 37nM for dopamine in rat brain synaptosomes. The drug's at the serotonin 5-HT2A receptor is 8.47nM and its at the receptor is 107%. The of 5-fluoro-AMT for MAO-A is 180 to 450nM. This is similar to the potency of αMT, para-methoxyamphetamine, and 4-methylthioamphetamine.5-Fluoro-αMT induces the head-twitch response, a behavioral proxy of psychedelic-like effects, in rodents. It is also known to reverse reserpine-induced behavioral depression, suggesting that it has antidepressant- or stimulant-like effects as well. 5-Fluoro-AMT does not substitute for cocaine in drug discrimination tests but did substitute for cocaine in monkeys. It does not facilitate intracranial self-stimulation in rodents.
Chemistry
Analogues
s of 5-fluoro-AMT include 5-fluorotryptamine, 5-fluoro-DMT, 5-fluoro-AET, and BK-5F-NM-AMT, as well as 5-chloro-αMT, 6-fluoro-AMT, 7-chloro-AMT, 7-methyl-αET, 5-API, and flucindole, among others.BK-5F-NM-AMT, the N-methyl and β-keto derivative of 5-fluoro-AMT, is a serotonin–dopamine releasing agent analogously to 5-fluoro-AMT. In contrast to 5-fluoro-AMT and many other tryptamines however, BK-5F-NM-AMT is inactive as an agonist of serotonin receptors including the 5-HT1, 5-HT2, and 5-HT3 receptors and is inactive as a monoamine oxidase inhibitor.